About SuboxoneŽ Treatment and Drug Addiction
Using Evidence Based Medicine Techniques to Overcome Opitate Dependencies
The medical specialists at BAART are experienced with the use of a medication based drug treatment known as Suboxone or buprenorphine. While opiate dependency to drugs like Methadone, Oxycontin and Heroin are challenging addictions, advances in the rehabilitation field have found Suboxone, accompanied with the appropripate counseling support, to be a proven and effective way of treating drug addiction. Today, medications and drugs like Percocet and Vicodin are often prescribed by physicians in order to alleviate painful symptoms or conditions; but based on how powerful these drug are, it is also common for a patient to develop a potentially dangerous opiate dependency towards these drugs. If a patient does develop an addiction, and stops using the drug on their own, they will most likely develop a range of serious physical withdrawal symptoms such as nausea, vomiting, muscle pain, headaches, anxiety and sleeplessness.
Suboxone acts as a medical intervention to alleviate the painful symptoms of prescription medication withdrawal, in order to allow successful recovery and encourage a smooth continuance of day to day life for the patient. Once Suboxone treatment begins, a patient will experience a dramatic reduction in withdrawal symptoms and also a suppression of harmful drug cravings.
While Suboxone is a crucial first step in combatting your addiction, our professionals encourage patients to participate in a counseling program throughout the process as well. Like all of our drug rehabilitation programs, we know that individual planning for each patient will result in optimal success. Therefore, after an initial assessment meeting with a patient, we will develop a tailored plan for them incorporating Suboxone treatment into their recovery process, as well as any other necessary aids. For more information on this proven and unique drug treatment method, please contact your local BAART facility today.

